The Claim

Knockdown of SLC38A2 in A549 lung adenocarcinoma cells under glucose deprivation reduces glutamine utilization, decreases ATP production, suppresses glycolysis, inhibits proliferation, migration, and invasion, and increases apoptosis, demonstrating that SLC38A2 is necessary for metabolic adaptation and survival under nutrient stress.

Source: Phosphoenolpyruvate carboxykinase 2 activation of the AMPK–CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
48score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In lung cancer cells deprived of glucose, reducing the SLC38A2 protein decreases energy production, slows cell growth and movement, and increases cell death, showing that SLC38A2 is required for these cells to survive low-glucose conditions.

See the scientific wording

Under glucose deprivation, knockdown of SLC38A2 in A549 lung adenocarcinoma cells reduces glutamine utilization, decreases ATP production, suppresses glycolysis, and inhibits malignant behaviors including proliferation, migration, and invasion, while increasing apoptosis, indicating that SLC38A2 is necessary for metabolic adaptation and survival under nutrient stress.

Why this might work

When sugar is scarce, cancer cells use glutamine as an alternative fuel. A transporter called SLC38A2 pulls glutamine into the cell, where it is broken down to replenish key molecules needed to keep the energy factory running. This allows the cell to keep making ATP and lactate, which fuel growth, movement, and survival. Without this transporter, glutamine cannot enter, energy production collapses, and the cell dies.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Phosphoenolpyruvate carboxykinase 2 activation of the AMPK–CEBPB axis to enhance glutamine utilization to promote glycolysis and malignant behavior in adenocarcinomas cells under glucose deprivation

    When lung cancer cells are starved of sugar, they rely on another nutrient called glutamine to survive and grow. This study shows that blocking a specific transporter (SLC38A2) stops the cells from using glutamine, which slows their growth and makes them more likely to die.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.